Beta-turn secondary structure and melanocortin ligands.
The melanocortin pathway has emerged during this past decade as an important target area for the discovery and development of therapeutic agents related to obesity and type 2 diabetes. This peptide-G-protein coupled receptor (GPCR) pathway has evolved from peptide-based ligands to small molecules possessing a variety of different molecular scaffolds. Herein, we summarize the originating hypothesis of the importance of the reverse beta-turn secondary structure for agonist ligand potency at the melanocortin receptors and how that information was utilized for the discovery of small molecules based upon this type of turn structure.
Haslach
Erica M
EM
Department of Medicinal Chemistry, University of Florida, PO Box 100485, Gainesville, FL 32610, USA.
Schaub
Jay W
JW
Haskell-Luevano
Carrie
C
D000595:Amino Acid Sequence; D008024:Ligands; D053486:Melanocortins / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology; D017433:Protein Structure, Secondary; D044101:Receptors, Melanocortin / Q000819:agonists* / Q000378:metabolism; D013237:Stereoisomerism
D008024:Ligands; D053486:Melanocortins; D044101:Receptors, Melanocortin